Whatever Happened to Human Experimentation?
By Carl Elliott,
Hastings Center Report
| 01. 01. 2016
Untitled Document
Several years ago, the University of Minnesota hosted a lecture by Alan Milstein, a Philadelphia attorney specializing in clinical trial litigation. Milstein, who does not mince words, insisted on calling research studies “experiments.” “Don’t call it a study,” Milstein said. “Don’t call it a clinical trial. Call it what it is. It’s an experiment.”
Milstein’s comments made me wonder: when was the last time I heard an ongoing research study described as a “human experiment”? The phrase is now almost always associated with abuses. Ask people what they think of when they hear the phrase “human experimentation” and chances are they will reply, “Nazis.” James Jones gave his book Bad Blood the subtitle The Tuskegee Syphilis Experiment. Philip Zimbardo’s controversial study on the psychology of imprisonment is commonly referred to as “The Stanford Prison Experiment.” New Zealand’s most notorious research scandal, on women with cervical carcinoma in situ at Auckland Women’s Hospital, is known colloquially as “The Unfortunate Experiment.” Asking a prospective subject to sign up for a medical experiment would probably get roughly the same response...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...